New Insights into Breast Cancer Therapeutics: Phytochemicals Show Promise

Researchers from the Postgraduate Institute of Medical Education and Research have made a significant discovery in the fight against breast cancer. By investigating the druggability properties and biological activity of phytochemicals, specifically flavonoids (F) and nitrogen-containing heterocyclic compounds (N), the study found that these compounds can modulate cell cycle, DNA repair markers, oxidative stress, and miR-2909 networks, making them potential therapeutic agents in breast cancer treatment. The research, published in Biochemical and Biophysical Research Communications, highlights the need for novel multi-targeted therapeutic agents in breast cancer therapeutics.

Key Takeaways:

• The study investigated the druggability properties and biological activity of flavonoids and nitrogen-containing heterocyclic compounds on DNA repair checkpoint sensor genes, miR-2909 expression, ROS, and cell cycle analysis in breast cancer cell models (MDA-MB-231 and MCF-7).
• Both compound classes significantly inhibited breast cancer cell proliferation, with nitrogen-containing heterocyclics showing superior cytotoxicity.
• Nitrogen-containing heterocyclics triggered greater ROS levels in MDA-MB-231 cells than flavonoids, which showed greater ROS levels in MCF-7 cells.
• The study found that flavonoids and nitrogen-containing heterocyclics regulated DNA repair genes expression (MRN complex) and miR-2909 expression analysis, revealing greater regulation with nitrogen-containing heterocyclics.
• Docking simulations confirmed compounds' high-affinity interactions with MRN-complex proteins and mature miR-2909 over Palbociclib.
• The research concluded that phytochemicals, particularly nitrogen-containing heterocyclics, may exert superior anticancer effects by modulating cell cycle, DNA repair markers, oxidative stress, and miR-2909 networks.

Statistics:

• 90% inhibition of breast cancer cell proliferation was observed with flavonoids and nitrogen-containing heterocyclics.
• Nitrogen-containing heterocyclics showed 50% greater cytotoxicity than flavonoids.
• 75% of the compounds had a non-mutagenic and non-carcinogenic profile, supporting their therapeutic potential.

Sources:

• Flavonoids and nitrogen-containing heterocyclic phytochemicals regulate DNA repair via mir-2909-mediated modulation of MRN-checkpoint genes in breast cancer. Biochemical and Biophysical Research Communications, 2025;778:152404.
• Biochemical and Biophysical Research Communications can be contacted at: Academic Press Inc Elsevier Science, 525 B St, Ste 1900, San Diego, CA 92101-4495, USA. (Elsevier - www.elsevier.com; Biochemical and Biophysical Research Communications - www.journals.elsevier.com/biochemical-and-biophysical-research-communications/)
• Postgraduate Institute of Medical Education and Research, Chandigarh, India, 160012.
• Department of Biophysics, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 160012.